Evidence Hub

Prevalence of Acinetobacter baumannii with multiple drug resistance isolated from patients with ventilator-associated pneumonia from 2010 to 2020 in the world: a systematic review and meta-analysis

Afra Panahi, Fazel Dehvan, Seyyed Nima Naleini, S. Rouhi, Seyyede Maryam Bechashk, R. R. Darehbagh, Safoora Derakhshan, H. Jafarpour

Reviews and Research in Medical Microbiology, 2023

4 citations

Abstract

Acinetobacter baumannii is a major cause of ventilator-associated pneumonia (VAP). The high resistance of this bacterium to antibiotics makes its control and treatment difficult. This study aimed to investigate the prevalence of multidrug-resistant (MDR) A. baumannii isolated from patients with VAP. Indexed articles in international databases on MDR A. baumannii isolated from patients with VAP were reviewed in a period from 2011 to 2020. Articles with full text in English were included and review articles, abstracts, and articles in languages other than English were excluded from the study. A random effect model using Meta R software, version 2.13 with a 95% confidence interval (CI) was used for data analysis. The final prevalence of A. baumannii isolated from patients with VAP in the above-mentioned period was 0.38 (95% CI: 0.26–0.52). Higher and lower prevalence rates were observed in Asia (0.43 (95% CI: 0.42−0.44)) and Africa (0.10 (95% CI: 0.07−0.12)), respectively. The overall prevalence rates of MDR, extensively drug-resistant (XDR), and pan drug-resistant bacteria (PDR) A. baumannii were reported as 0.71 (95% CI: 0.59−0.81), 0.73 (95% CI: 0.52−0.90), and 0.40 (95% CI: 0.28−0.52), respectively. The total prevalence of A. baumannii in males (0.57 (95% CI: 0.48−0.65)) was higher than the prevalence in females (0.35 (95% CI: 0.28−0.42)). VAP was directly related to different years, continents, drug resistance, and gender (P < 0.0001). VAP has particular importance in the…

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free